Dow Up0.08% Nasdaq Down0.30%

More On SAC.DE



News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


Sanochemia Pharmazeutika AG (SAC.DE)

1.31 Down 0.04(2.89%) Sep 19, 9:28AM EDT
ProfileGet Profile for:
Sanochemia Pharmazeutika AG
Boltzmanngasse 11
Vienna, 1090
Austria - Map

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

SANOCHEMIA Pharmazeutika AG, a specialty pharmaceuticals company, develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology. It offers active pharmaceutical ingredients (APIs); radiological products, including a range of X-ray imaging agents and the MRT imaging agents; sterile and semi-sterile liquid and semi-liquid presentations comprising antibiotics and hormones; and veterinary pharmaceuticals. The company’s product pipeline includes Tolperisone, a centrally acting muscle relaxant; and PVP hypericine, a photoactive substance for the diagnosis and treatment of bladder carcinomas. It also offers contract manufacturing services; and manufactures clinical diagnostics. The company was founded in 1990 and is headquartered in Vienna, Austria.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Sanochemia Pharmazeutika AG

Key Executives 
Ms. Eveline Frantsits ,
Chairwoman of the Supervisory Board and Exec. Officer
Dr. Werner Josef Frantsits Ph.D.,
Founder, Chief Exec. Officer and Member of the Management Board
Dr. Johannes M. Respondek ,
Managing Director and Member of the Supervisory Board
Dr. Heinrich Unger-Krayer ,
Exec. Officer and Member of the Supervisory Board
Stefan Welzig ,
Chief Financial Officer, Chief Technical Officer and Member of the Management Board
Amounts are as of Dec 31, 2005 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in EUR.